Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Current Assets (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Current Assets data on record, last reported at $96.5 million in Q3 2025.

  • For Q3 2025, Current Assets fell 5.04% year-over-year to $96.5 million; the TTM value through Sep 2025 reached $96.5 million, down 5.04%, while the annual FY2024 figure was $96.3 million, 9.35% down from the prior year.
  • Current Assets reached $96.5 million in Q3 2025 per UTMD's latest filing, up from $94.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $107.1 million in Q1 2024 and bottomed at $66.6 million in Q1 2021.
  • Average Current Assets over 5 years is $90.3 million, with a median of $95.1 million recorded in 2023.
  • Peak YoY movement for Current Assets: soared 32.89% in 2021, then dropped 10.03% in 2025.
  • A 5-year view of Current Assets shows it stood at $73.2 million in 2021, then rose by 22.91% to $89.9 million in 2022, then rose by 18.18% to $106.3 million in 2023, then fell by 9.35% to $96.3 million in 2024, then rose by 0.21% to $96.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $96.5 million in Q3 2025, $94.4 million in Q2 2025, and $96.4 million in Q1 2025.